These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15251109)

  • 21. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.
    Derry PS
    Womens Health Issues; 2004; 14(6):212-9. PubMed ID: 15589771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hold the hormones? The good and the bad about postmenopausal estrogen therapy.
    Nemecek S
    Sci Am; 1997 Sep; 277(3):38, 40. PubMed ID: 9304196
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel cardiac markers.
    Alder R
    Adv Nurse Pract; 2009 Jun; 17(6):24-7; quiz 28. PubMed ID: 20000180
    [No Abstract]   [Full Text] [Related]  

  • 26. Women's risk of heart disease: promoting awareness and prevention--a primary care approach.
    Schroetter SA; Peck SD
    Medsurg Nurs; 2008 Apr; 17(2):107-13. PubMed ID: 18517171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.
    Vitale C; Gebara O; Mercuro G; Wajngarten M; Silvestri A; Rossini P; Ramires JA; Fini M; Rosano GM
    Maturitas; 2005 Apr; 50(4):239-46. PubMed ID: 15780522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations on hormone replacement therapy: an answer to the 'one dose fits all' Women's Health Initiative study.
    Studd J
    Gynecol Endocrinol; 2007 Nov; 23(11):665-71. PubMed ID: 17943531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helping OB/GYN specialists screen midlife women for CHD.
    Med Manag Netw; 1999 Oct; 7(10):5-7. PubMed ID: 10623045
    [No Abstract]   [Full Text] [Related]  

  • 32. Variability of high-sensitivity C-reactive protein in chronic heart failure.
    Araújo JP; Friões F; Azevedo A; Lourenço P; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Cardiology; 2009; 113(3):180-3. PubMed ID: 19136826
    [No Abstract]   [Full Text] [Related]  

  • 33. Women and heart disease: new AHA guidelines. What oral health care professionals need to know.
    Perno Goldie M
    Int J Dent Hyg; 2004 Nov; 2(4):193-5. PubMed ID: 16451495
    [No Abstract]   [Full Text] [Related]  

  • 34. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute risk models for subtypes of breast cancer.
    Gail MH; Anderson WF; Garcia-Closas M; Sherman ME
    J Natl Cancer Inst; 2007 Nov; 99(22):1657-9. PubMed ID: 18000214
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevent cardiovascular disease in women.
    Holcomb SS
    Nurse Pract; 2004 Jul; 29(7):6-11. PubMed ID: 15238852
    [No Abstract]   [Full Text] [Related]  

  • 38. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke.
    Ridker PM
    Circulation; 2003 Sep; 108(12):e81-5. PubMed ID: 14504253
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum high sensitivity C-reactive protein and cognitive function in elderly women.
    Komulainen P; Lakka TA; Kivipelto M; Hassinen M; Penttilä IM; Helkala EL; Gylling H; Nissinen A; Rauramaa R
    Age Ageing; 2007 Jul; 36(4):443-8. PubMed ID: 17537742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.